Showing results (11-20 of 148) with videos related to
Sort By:
Pageof 15
Journal of Immunological Methods|February 22, 2015
The novel multispecies Fc-specific Pseudomonas exotoxin A fusion protein α-Fc-ETA' enables screening of antibodies for immunotoxin developmentKatja Klausz, Christian Kellner, Stefanie Derer, et al.Cellular Immunology|May 17, 2015
γδ T cell activation by bispecific antibodiesHans-Heinrich Oberg, Christian Kellner, Daniel Gonnermann, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 27, 2012
Impact of epidermal growth factor receptor (EGFR) cell surface expression levels on effector mechanisms of EGFR antibodiesStefanie Derer, Philip Bauer, Stefan Lohse, et al.Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Fc Glyco- and Fc Protein-Engineering: Design of Antibody Variants with Improved ADCC and CDC ActivityChristian Kellner, Stefanie Derer, Katja Klausz, et al.Frontiers in Immunology|January 8, 2015
Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based ImmunotherapyHans-Heinrich Oberg, Christian Kellner, Matthias Peipp, et al.Plos One|August 11, 2012
Enhanced ADCC activity of affinity maturated and Fc-engineered mini-antibodies directed against the AML stem cell antigen CD96Sahar Mohseni Nodehi, Roland Repp, Christian Kellner, et al.Oncotarget|November 5, 2017
A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display librariesKatja Klausz, Michael Cieker, Christian Kellner, et al.Frontiers in Immunology|May 5, 2018
Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer CellsHans H Oberg, Christian Kellner, Daniel Gonnermann, et al.American Journal of Nephrology|October 26, 2013
Antibody-dependent cellular cytotoxicity in patients on chronic hemodialysisTill Koch, Stefanie Derer, Matthias Staudinger, et al.Geburtshilfe Und Frauenheilkunde|June 25, 2021
New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast CancerDiana Lüftner, Matthias PeippPageof 15